Are you Dr. Mobashery?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 30 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
50 Pequot Ave
Ms 6025-B3125
New London, CT 06320Phone+1 860-732-1033- Is this information wrong?
Summary
- Dr. Niloufar Mobashery, MD is an infectious disease specialist in New London, Connecticut. She is currently licensed to practice medicine in Pennsylvania and California.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Infectious Disease, 2002 - 2004
- University of MarylandResidency, Internal Medicine, 1999 - 2002
- Weill Cornell MedicineClass of 1999
Certifications & Licensure
- CA State Medical License 2002 - 2026
- PA State Medical License 2008 - 2014
Publications & Presentations
PubMed
- 25 citationsGlecaprevir–pibrentasvir to treat chronic hepatitis C virus infection in Asia: two multicentre, phase 3 studies—a randomised, double-blind study (VOYAGE-1) and an open...Lai Wei, Guiqiang Wang, Negar N. Alami, Wen Xie, Jeong Heo, Qing Xie, Mingxiang Zhang, Yoon Jun Kim, Seng Gee Lim, Linda M Fredrick, Wenjing Lu, Wei Liu, Hari V. Kallu...> ;The Lancet. Gastroenterology & Hepatology. 2020 Sep 1
- 2 citationsOmbitasvir/paritaprevir/ritonavir plus ribavirin for 24 weeks in patients with HCV GT4 and compensated cirrhosis (AGATE-I Part II).Tarik Asselah, Negar N. Alami, Christophe Moreno, Stanislas Pol, Stylianos Karatapanis, Michael Gschwantler, Yves Horsmans, Ioannis S. Elefsiniotis, Dominique Larrey, ...> ;Health Science Reports. 2019 Mar 1
- 2 citationsPharmacokinetics of Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir in Healthy Chinese Subjects and HCV GT1b-Infected Chinese, South Korean and Taiwanese Patients.Jiuhong Zha, Bifeng Ding, Haoyu Wang, Weihan Zhao, Chen Yu, Katia Alves, N. Mobashery, Yan Luo, Rajeev M. Menon> ;European Journal of Drug Metabolism and Pharmacokinetics. 2019 Feb 1
- Join now to see all